1 |
Conola BS, Daniel SM, Christopher M, et al (2000). Baker. Knowledge, Attitudes, and Screening Practices Among Older men regarding prostate cancer. Am J of Public Health, 90, 1591-600.
|
2 |
Elsayed IS, Malcolm AM, Jawad A Al-Lawati, et al (2009). Cancer epidemiology and control in the Arab world-past present and future. Asian Pac J Cancer Prev, 10, 3-16.
|
3 |
Ferlay J, Shin HR, Bray F, et al (2008). GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 10.
|
4 |
Ghafoor M, Schuyten R, Bener A (2003). Epidemiology of prostate cancer in United Arab Emirates. Med J Malaysia, 58, 712-6.
|
5 |
Hamashima C, Nakayama T, Sagawa M, Saito H, Sobue T (2009). The Japanese guideline for prostate cancer screening. Jpn J Clin Oncol, 39, 339-51.
DOI
|
6 |
Hoffman RM (2011). Clinical practice. Screening for prostate cancer. N Engl J Med, 365, 2013-9.
DOI
ScienceOn
|
7 |
Ilic D, O'Connor D, Green S, Wilt TJ (2011). Screening for prostate cancer: an updated Cochrane systematic review. BJU Int, 107, 882-91.
DOI
|
8 |
Jordan Cancer Registry (2009). Non-communicable diseases Directorate. Cancer Incidence in Jordan, 2009.
|
9 |
Lin K, Lipsitz R, Miller T, Janakiraman S (2008). U.S. preventive services task force. benefits and harms of prostate-specific antigen screening for prostate cancer. Ann Intern Med, 149, 192-9.
DOI
ScienceOn
|
10 |
Madu CO, Lu Y (2010). Novel diagnostic biomarkers for prostate cancer. J Cancer, 1, 150-77.
|
11 |
Marilynn Marcione (2011). Prostate testing's dark side: Men who were harmed. Associated Press. http://apnews.excite. com/article/20111012/D9QAUS2O0.html.
|
12 |
Naomi NM, Curtis F, Malcolm C (2003). Early detection of prostate cancer among black and white men. Californian J Health Promotion, 1, 149-55.
|
13 |
Pereira de Paiva E, Salvador da Motta MC, Griep RH (2010). Knowledge, attitudes, and practices regarding the detection of prostate cancer. Acta Paul Enferm, 23, 88-93.
DOI
|
14 |
Purvis CC, Merritt TL, Ross LE, John LV, Jorgensen CM (2004). To screen or not to screen, when clinical guidelines disagree: primary care physicians' use of the PSA test. Prev Med, 38, 182-91.
DOI
|
15 |
Rabah DM, Arafa MA (2010). Prostate cancer screening in a Saudi population: an explanatory trial study. Prostate Cancer Prostatic Diseases, 13, 191-4
DOI
ScienceOn
|
16 |
Ravichandran K, Al-Hamdan-NA, Mohamed G (2011). Knowledge, attitude and behavior among Saudis towards cancer preventive practice. J Family & Community Med, 18, 135-42.
DOI
ScienceOn
|
17 |
Saudi Cancer Registry (2007). Cancer incidence and survival report 2007.
|
18 |
Roberts A (2010). Barriers preventing earlt detection of prostate cancer in black African/Carribean men living in Westminster. http://westminstercitypartnership.org.uk/
|
19 |
Schroder FH, Hugosson J, Roobol MJ, et al (2009). ERSPC Investigators. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med , 360, 1320-8.
DOI
|
20 |
Sheridan SL, Felix K, Pignone MP, Lewis CL (2004). Information needs of men regarding prostate cancer screening and the effect of a brief decision aid. Patient Edu Couns, 54, 345-51.
DOI
|
21 |
Boyle P, Levin B (2008). Lyon. International Agency For research On cancer; World cancer Report, 2008.
|
22 |
Al-Hamdan N, Ravichandran K, Al-Sayyad J, et at (2009). Incidence of cancer in gulf cooperation council countries, 1998-2001. East Mediterr Health J, 15, 600-11.
|
23 |
Arafa MA, Rabah DM, Abdel-Gawad E, et at (2010). Association of physicians' knowledge and behavior with prostate cancer counseling and screening in Saudi Arabia. Saudi Med J, 31, 179-84.
|
24 |
Arnold-Reed DE, Hince DA, Bulsara MK, et al (2008). Knowledge and attitudes of men about prostate cancer. MJA, 189, 312-14.
|